Skip to main content
NaltrexoneReviews home

Guide

Naltrexone: What It Is Used For and How It Works

By Naltrexone Reviews Editorial TeamUpdated 29 sourcesHow we check

Short answer

Naltrexone is a prescription medicine that blocks opioid receptors, FDA-approved in 1984 to block the effects of opioids and in 1994 for alcohol dependence. It comes as a generic 50 mg daily tablet or as Vivitrol, a 380 mg shot every 4 weeks. It is not an opioid or habit-forming, and you must be off opioids before starting.1-3

Key takeaways

  • For alcohol, the benefit is modest. In pooled trials, for every 11 people who took the tablet instead of a placebo, 1 more avoided a return to heavy drinking.4
  • You can start the tablets while still drinking, according to NIAAA, and drinking on naltrexone does not make you sick.2,5
  • For opioid use disorder, daily pills showed no clear benefit over placebo in trials, largely because people stopped taking them, and the monthly shot is generally recommended instead.6,7
  • After you stop, an opioid dose you once handled can kill you, because your tolerance has dropped.2

Naltrexone at a glance

Naltrexone at a glance

  • Generic name

    Details
    Naltrexone hydrochloride (tablets); naltrexone (Vivitrol)2,3
  • Drug class

    Details
    Opioid antagonist (blocker), with no opioid agonist properties2
  • FDA-approved for

    Details
    Tablets: alcohol dependence, and blocking the effects of opioids. Vivitrol: alcohol dependence in people who can stop drinking before the first shot, and preventing relapse to opioid dependence after detox.2,3
  • Usual dose

    Details
    One 50 mg tablet a day for most people. Vivitrol: 380 mg into a buttock muscle every 4 weeks.2,3 Details: naltrexone dosage
  • Brand names

    Details
    ReVia, the original tablet brand, is discontinued; tablets are sold as generics. Vivitrol is the only brand of the shot.8 More: naltrexone brand names
  • Controlled substance?

    Details
    No; federal law excludes it from Schedule II9
  • Boxed warning

    Details
    None on the current tablet or Vivitrol labels2,3
  • Pregnancy

    Details
    No adequate studies in pregnant women; use only if the benefit justifies the risk2; see naltrexone and pregnancy
  • Under 18

    Details
    Safety not established2
  • Cash price, October 17, 2026

    Details
    Tablets: set by your pharmacy; Vivitrol from $1,758.09 a shot. Full breakdown: naltrexone cost · Vivitrol cost10

Two approved uses, three off-label or combination uses

Two approved uses, three off-label or combination uses

  • Use: Alcohol use disorder

    Status
    FDA-approved: tablets since 1994, Vivitrol since 20061,8
    Form and dose
    50 mg tablet daily, or the monthly shot
  • Use: Opioid use disorder, after detox

    Status
    FDA-approved: tablets since 1984 to block opioids, Vivitrol since 2010 to prevent relapse1,8
    Form and dose
    The shot is generally preferred7
    Read more
    Vivitrol
  • Use: Taking it only before drinking (the Sinclair Method)

    Status
    Off-label; the label's dosing is daily2
    Form and dose
    A tablet taken only on drinking days, before drinking
  • Use: Low-dose naltrexone (LDN) for chronic pain, autoimmune and other conditions

    Status
    Off-label11; no low-dose product is listed in the FDA drug directory, so it is compounded12
    Form and dose
    Usually 0.5 to 6 mg a day, most often 4.5 mg11
  • Use: Weight management

    Status
    Approved only as Contrave, a combination with bupropion (2014)8,13
    Form and dose
    Up to 32 mg naltrexone a day in extended-release tablets13

For alcohol, the American Psychiatric Association recommends offering naltrexone or acamprosate to people with moderate to severe alcohol use disorder who prefer medication or have not improved with other treatment.14 Disulfiram, off-label topiramate and the other pills to stop drinking are compared on their own page.

For LDN, a 2026 review of 105 studies found that early positive results from uncontrolled studies "were rarely replicated in placebo-controlled trials."11

How naltrexone works: it blocks opioid receptors

Naltrexone attaches to the body's opioid receptors, most tightly to the mu receptor, and does not switch them on.3 It competes with opioids for those receptors. While it is in place, heroin and opioid painkillers have little or no effect. In studies, a 50 mg tablet blocked the effects of 25 mg of injected heroin for as long as 24 hours; doubling or tripling the dose stretched that to about 48 or 72 hours.2

The block can be overpowered. Someone who takes large amounts of opioids to get past it can have a fatal overdose.2

Alcohol. How naltrexone lowers drinking is not fully understood; animal research points to the body's own opioid system.2 The working explanation is that it blocks the opioid receptors involved in the rewarding effects of drinking.5 In laboratory studies, people on naltrexone reported less craving and less stimulation from alcohol, and more sedation; the effects were small.15 What drinking feels like on it is covered on drinking on naltrexone, and the alcohol research on the AUD page.

What it does not do.

  • It produces no high and no opioid effect, and it was not linked to tolerance or dependence.2
  • It causes no Antabuse-like reaction to alcohol.2
  • In someone dependent on opioids, it sets off withdrawal (see below).2

In the body. A tablet is absorbed quickly, with peak blood levels within an hour. The liver breaks down most of it on the first pass, and its main breakdown product, 6-beta-naltrexol, is also active.2

It helps with drinking modestly; for opioids the shot has the evidence

Alcohol. The tablet label sets expectations at "a modest improvement in the outcome of conventional treatment."2 Across pooled trials, 11 people needed to take naltrexone for 1 more to avoid a return to heavy drinking, and the 95% confidence interval ran from 5 to 41.4 Across 50 trials, heavy drinking was 17% less likely on naltrexone, with no statistically significant effect on whether people drank at all.16

Opioids. A Cochrane review of 13 trials (1,158 people) found daily pills no better than placebo, except in studies where people were made to take them.6 In a placebo-controlled trial of the Vivitrol shot after detox, people on it had confirmed opioid-free results in a median 90% of weeks, against 35% on placebo.17

The trials, including the negative ones, are covered one by one on does naltrexone work? When to expect a change is covered on how long naltrexone takes to work.

The FDA has approved a tablet and a shot, nothing else

Tablets. Seven generic naltrexone tablet approvals are listed as prescription products in Drugs@FDA.8 Why 50 mg is the only strength you will see is explained on naltrexone dosage. Former tablet brands (ReVia, Depade) and each one's status are listed on naltrexone brand names.

The shot. Vivitrol is made by Alkermes. An unbranded version distributed by Amneal is sold under the same FDA approval, so it is not a generic.18 A true generic from Teva was approved in 2023 and is now listed as discontinued.8 Pill and shot are compared on naltrexone vs Vivitrol.

Implants. Naltrexone pellets placed under the skin are not FDA-approved in the US: naltrexone implant.

Compounded versions. LDN capsules and some telehealth formulations are made by compounding pharmacies. Compounded drugs are not FDA-approved, and the FDA does not check their safety, effectiveness or quality before sale.12,19 How to tell them apart is explained on generic vs compounded naltrexone.

Opioids must be out of your system before the first dose

Opioids. Stop short-acting opioids, including tramadol, for at least 7 to 10 days first. After methadone or buprenorphine, withdrawal can be triggered for as long as 2 weeks.2 Opioid cough, cold and diarrhea medicines count. A clinic may check with a urine test or a naloxone challenge, but the label says no method is completely reliable.2 Withdrawal set off by naltrexone usually starts within 5 minutes, can last up to 48 hours, and has put people in hospital.2 For opioid use disorder, the tablet label starts with 25 mg, then 50 mg a day if there are no withdrawal signs.2

Alcohol. Some patient pages still say you must stop drinking and finish detox before the first tablet. US guidance for clinicians says naltrexone "can be started while a patient is still drinking," and it can be continued after a relapse.5,7 Vivitrol is different: its alcohol approval covers people who stop drinking before the first shot.3 If you drink heavily every day, stopping suddenly can be dangerous, so plan withdrawal with a clinician.

How long. England's NICE guideline starts the tablets after assisted withdrawal, stops them if drinking persists 4 to 6 weeks in, and otherwise prescribes them for up to 6 months, or longer if they are helping.20 Missed doses and schedules are covered on naltrexone dosage.

Most side effects are mild; the serious risks involve opioids and the liver

In an open-label safety study of about 570 people treated for alcohol use disorder, the most common new side effects were nausea (10%), headache (7%), dizziness (4%), nervousness (4%) and tiredness (4%).2 Overall, it is generally safe and well tolerated.7 The shot adds injection-site reactions.3 Rates against placebo, and what helps, are on naltrexone side effects and Vivitrol side effects.

  • Overdose after stopping. Tolerance falls, so a smaller opioid dose than before can be fatal. Read the full warning and keep naloxone at home.2

  • Liver. The label warns of hepatitis and liver injury. In placebo-controlled studies, doses up to 300 mg a day, several times the usual dose, injured the liver in a substantial share of people.2 FDA removed the boxed liver warning from the ReVia tablet label in October 2013.21 See naltrexone liver tests.

  • Mood. People taking it for alcohol or opioids should be watched for depression or suicidal thinking.2 If you have thoughts of suicide, call or text 988.22

  • Medicines that may not work. Opioid painkillers, cough medicines and diarrhea medicines may have little effect. Carry a card saying you take naltrexone.2 Taking it with disulfiram, which can also harm the liver, is not ordinarily recommended, and Contrave's label advises against adding other naltrexone products.2,13

  • Driving. It can cause dizziness, so wait to drive until you know how it affects you.2

Naltrexone is not naloxone, and it is not Suboxone

Naltrexone is not naloxone, and it is not Suboxone

  • Drug: Naltrexone (tablets, Vivitrol)

    What it does
    Daily or monthly blocker that helps prevent relapse
    Controlled substance?
    No9
    More
    This page
  • Drug: Naloxone (Narcan and other sprays)

    What it does
    Rescue drug that reverses an opioid overdose; nasal sprays are sold over the counter23
    Controlled substance?
    No9
  • Drug: Buprenorphine with naloxone (Suboxone)

    What it does
    Daily film under the tongue; buprenorphine partly switches opioid receptors on1
    Controlled substance?
    Yes, Schedule III24

A tablet blocks opioids for about a day; the shot for about a month

Naltrexone's half-life is about 4 hours and 6-beta-naltrexol's about 13 hours.2 One Vivitrol shot blocks opioids for about 28 days.3 Drug tests, surgery and the timing of the last dose are covered on how long naltrexone stays in your system.

Not a controlled substance, and no dependence in studies

Federal rules exclude naltrexone from the opioid schedule, so it carries none of the extra prescribing rules that apply to controlled drugs.9 It does not lead to physical or psychological dependence, and NIAAA lists it among the nonaddictive alcohol medicines.2,25 It still needs a prescription. See is naltrexone a controlled substance? and is naltrexone addictive?

Any licensed prescriber can write it

No special license or registration is needed: any practitioner licensed to prescribe medicines can prescribe it.26 NIAAA tells clinicians the alcohol medicines are "neither addicting nor complicated to prescribe," and that primary care can offer them.5 Yet in 2024, 2.5% of people in the US aged 12 and older with alcohol use disorder (about 697,000 of an estimated 28.0 million) received medication for it.27,28

You can ask your own doctor, or compare 13 online programs, their prices and whether they use generic or compounded naltrexone on where to get naltrexone online. We have full reviews of Oar Health, Reframe, Ria Health and Sunnyside.

Naltrexone through the years

Naltrexone through the years

  • Year: 1960s

    Event
    Naltrexone is synthesized to block the euphoric effects of morphine1
  • Year: 1984

    Event
    FDA approves the tablets to block the effects of opioids1,8
  • Year: 1994

    Event
    FDA approves the tablets for alcohol dependence1
  • Year: 2006

    Event
    Vivitrol approved for alcohol dependence1,8
  • Year: 2009

    Event
    Embeda, a morphine capsule that also contained naltrexone, approved; now listed as discontinued8
  • Year: 2010

    Event
    Vivitrol approved to prevent relapse to opioid dependence1,8
  • Year: 2013

    Event
    Boxed liver warning removed from the ReVia tablet label21
  • Year: 2014

    Event
    Contrave (naltrexone with bupropion) approved for weight management8
  • Year: 2016

    Event
    Troxyca ER, an oxycodone capsule that also contained naltrexone, approved; now listed as discontinued8
  • Year: 2023

    Event
    First generic of the shot (Teva) approved; now listed as discontinued8

Every naltrexone page on this site

About the drug

Every naltrexone page on this site: About the drug

Topic guides

Every naltrexone page on this site: Topic guides

Share your experience

Have you taken naltrexone, as a tablet, the shot or at a low dose? Tell us how it went.

Frequently asked questions

What is naltrexone used for?

It is FDA-approved for alcohol use disorder and, after detox, for opioid use disorder; low-dose and before-drinking uses are off-label. See approved and off-label uses.2,3,11

How does naltrexone work?

It blocks opioid receptors, so opioids have little effect, and it is thought to dull the reward from drinking. See how it works.2,5

Is naltrexone the same as naloxone (Narcan)?

No. Both block opioid receptors, but naloxone is a short-acting rescue drug for overdoses, while naltrexone is taken daily or monthly to prevent relapse. See naltrexone vs naloxone.2,23

Can you drink alcohol while taking naltrexone?

It causes no sickness reaction if you drink, and the tablets can be started while still drinking. See drinking on naltrexone.2,5

What should I avoid while taking naltrexone?

Avoid all opioids, including opioid cough and diarrhea medicines, and never take extra opioids to get past the block. See risks and interactions and the full list in what to avoid on naltrexone.2

How much weight can you lose with naltrexone?

Naltrexone alone is not approved for weight loss. In a 56-week trial of Contrave, which adds bupropion, average weight loss was 5.4% of body weight, against 1.3% on placebo. See naltrexone and bupropion (Contrave).13

Why don't more doctors prescribe naltrexone?

NIAAA calls alcohol medicines vastly underused and says some patients hesitate because of misinformation; no special license is needed. See who can prescribe it.5,26

Is there a generic version of naltrexone?

Yes. The tablets are sold only as generics; the shot's only generic is listed as discontinued. See tablets and the shot.8

How we checked

  • Drug facts come from the current tablet, Vivitrol and Contrave labels on DailyMed. Approval dates come from FDA application records and SAMHSA's TIP 63.1-3,8,13
  • Evidence comes from the 2023 AHRQ review, Cochrane reviews, one Vivitrol opioid trial and a 2019 laboratory meta-analysis, read as abstracts or summaries.4,6,15-17
  • Every figure was matched to a saved copy of its source on October 17, 2026.

References

29 sources, numbered in the order they are first cited (AMA style). Each is labelled by type so you can weigh it; commercial and media sources are never the only support for a clinical claim.

  1. 1.Substance Abuse and Mental Health Services Administration. Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63. Publication No. PEP21-02-01-002. SAMHSA; 2021. Accessed October 17, 2026. https://library.samhsa.gov/sites/default/files/pep21-02-01-002.pdfClinical guideline
  2. 2.Naltrexone hydrochloride tablets USP, 50 mg. Prescribing information. SpecGx LLC; revised May 2026. DailyMed SPL version 15. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06ff2d5a-e62b-4fa4-bbdb-01938535bc65FDA drug label
  3. 3.Vivitrol (naltrexone for extended-release injectable suspension). Prescribing information and Medication Guide. Alkermes, Inc.; revised May 2026. DailyMed SPL version 39. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd11c435-b0f0-4bb9-ae78-60f101f3703fFDA drug label
  4. 4.McPheeters M, O'Connor EA, Riley S, et al. Pharmacotherapy for alcohol use disorder: a systematic review and meta-analysis. JAMA. 2023;330(17):1653-1665. doi:10.1001/jama.2023.19761Systematic review / meta-analysis · Our summary of this study
  5. 5.Recommend evidence-based treatment: know the options. In: Core Resource on Alcohol. National Institute on Alcohol Abuse and Alcoholism. Revised May 8, 2025. Accessed October 17, 2026. https://www.niaaa.nih.gov/health-professionals-communities/core-resource-on-alcohol/recommend-evidence-based-treatment-know-optionsGovernment source
  6. 6.Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev. 2011;(4):CD001333. doi:10.1002/14651858.CD001333.pub4Systematic review / meta-analysis · Our summary of this study
  7. 7.Substance Abuse and Mental Health Services Administration. Prescribing Pharmacotherapies for Patients With Alcohol Use Disorder. Advisory. Publication No. PEP20-02-02-015. SAMHSA; 2021. Accessed October 17, 2026. https://library.samhsa.gov/sites/default/files/PEP20-02-02-015.pdfClinical guideline
  8. 8.Drugs@FDA application records for naltrexone products (including NDA 018932, NDA 021897, NDA 200063, NDA 022321, NDA 207621 and ANDA 213195). openFDA. US Food and Drug Administration. Accessed October 17, 2026. https://api.fda.gov/drug/drugsfda.json?search=products.active_ingredients.name:%22NALTREXONE%22&limit=100Government source
  9. 9.Schedule II, 21 CFR §1308.12 (2026). eCFR version as of October 1, 2026. Accessed October 17, 2026. https://www.ecfr.gov/current/title-21/chapter-II/part-1308/section-1308.12Government source
  10. 10.Vivitrol prices, coupons, copay cards & patient assistance. Drugs.com. Accessed October 17, 2026. https://www.drugs.com/price-guide/vivitrolCommercial source · Discount-card cash prices; not valid with insurance; prices change.
  11. 11.Gouda AHK, Aitcheson NEC, Steadman KJ. Low-dose naltrexone: what is the evidence? A narrative review. Adv Ther. 2026;43(7):2852-2870. doi:10.1007/s12325-026-03612-5Narrative review
  12. 12.NDC directory: generic name naltrexone. openFDA. US Food and Drug Administration. Accessed October 17, 2026. https://api.fda.gov/drug/ndc.json?search=generic_name:naltrexone&limit=100Government source
  13. 13.Contrave (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets. Prescribing information. Nalpropion Pharmaceuticals LLC; revised November 2025. DailyMed SPL version 27. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=485ff360-32c8-11df-928b-0002a5d5c51bFDA drug label
  14. 14.American Psychiatric Association. Guideline statement summary. In: The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder. American Psychiatric Association Publishing; 2018. Accessed October 17, 2026. doi:10.1176/appi.books.9781615371969Clinical guideline
  15. 15.Ray LA, Green R, Roche DJO, Magill M, Bujarski S. Naltrexone effects on subjective responses to alcohol in the human laboratory: a systematic review and meta-analysis. Addict Biol. 2019;24(6):1138-1152. doi:10.1111/adb.12747Systematic review / meta-analysis · Our summary of this study
  16. 16.Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev. 2010;(12):CD001867. doi:10.1002/14651858.CD001867.pub3Systematic review / meta-analysis · Our summary of this study
  17. 17.Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet. 2011;377(9776):1506-1513. doi:10.1016/S0140-6736(11)60358-9Randomized controlled trial · Our summary of this study
  18. 18.Naltrexone for extended-release injectable suspension (kit). Prescribing information. Amneal Pharmaceuticals LLC; January 2026. DailyMed SPL version 1. Accessed October 17, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6de5637f-d527-4228-af1a-3aae71155cb5FDA drug label · Sold under Vivitrol's NDA 021897 without the brand name. We could not verify a price or current availability.
  19. 19.Compounding and the FDA: questions and answers. US Food and Drug Administration. Content current as of September 16, 2025. Accessed October 17, 2026. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answersGovernment source
  20. 20.National Institute for Health and Care Excellence. Alcohol-Use Disorders: Diagnosis, Assessment and Management of Harmful Drinking (High-Risk Drinking) and Alcohol Dependence. Clinical guideline CG115. Published February 23, 2011. Updated October 21, 2014. Accessed October 17, 2026. https://www.nice.org.uk/guidance/cg115/chapter/RecommendationsClinical guideline
  21. 21.US Food and Drug Administration. Revia (naltrexone HCl) tablets: detailed view: safety labeling changes approved by FDA Center for Drug Evaluation and Research (CDER). MedWatch Safety Information. October 2013. Internet Archive capture November 9, 2015. Accessed October 17, 2026. https://web.archive.org/web/20151109023859/http://www.fda.gov/safety/medwatch/safetyinformation/ucm374896.htmGovernment source · Archived copy (Internet Archive).
  22. 22.988 Suicide & Crisis Lifeline. Accessed October 17, 2026. https://988lifeline.org/Nonprofit organization
  23. 23.FDA approves first over-the-counter naloxone nasal spray. News release. US Food and Drug Administration. March 29, 2023. Accessed October 17, 2026. https://www.fda.gov/news-events/press-announcements/fda-approves-first-over-counter-naloxone-nasal-sprayGovernment source
  24. 24.Controlled substances – alphabetical order. US Drug Enforcement Administration, Diversion Control Division. August 27, 2026. Accessed October 17, 2026. https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdfGovernment source
  25. 25.Understanding alcohol use disorder. National Institute on Alcohol Abuse and Alcoholism. Updated January 2025. Accessed October 17, 2026. https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/understanding-alcohol-use-disorderGovernment source
  26. 26.Naltrexone. Substance Abuse and Mental Health Services Administration. Updated December 22, 2025. Accessed October 17, 2026. https://www.samhsa.gov/substance-use/treatment/options/naltrexoneGovernment source
  27. 27.Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Table 5.21B: received medications for alcohol use disorder (MAUD) in past year: among people aged 12 or older; received MAUD in past year: among people aged 12 or older with past year alcohol use disorder; by demographic characteristics, percentages, 2023 and 2024. In: Results From the 2024 National Survey on Drug Use and Health: Detailed Tables. SAMHSA; 2025. Accessed October 17, 2026. https://www.samhsa.gov/data/sites/default/files/reports/rpt56484/NSDUHDetailedTabs2024/NSDUHDetailedTabs2024/2024-nsduh-detailed-tables-sect5pe.htmGovernment source
  28. 28.Alcohol treatment in the United States: age groups and demographic characteristics. National Institute on Alcohol Abuse and Alcoholism. Updated March 2026. Accessed October 17, 2026. https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-topics/alcohol-facts-and-statistics/alcohol-treatment-united-states-age-groups-and-demographic-characteristicsGovernment source
  29. 29.SAMHSA's National Helpline. Substance Abuse and Mental Health Services Administration. Updated June 9, 2023. Accessed October 17, 2026. https://www.samhsa.gov/find-help/helplines/national-helplineGovernment source

Medical disclaimer

This page is for general information only and is not medical advice. It does not replace advice from your own clinician or pharmacist. Don't start, stop or change a medicine without talking to your prescriber. If you drink heavily every day, stopping suddenly can be dangerous; get medical advice first. If you use opioids, starting naltrexone in either form can cause sudden, severe withdrawal. For free, confidential treatment referrals 24 hours a day, call SAMHSA's National Helpline at 1-800-662-4357.29

Full medical disclaimer.